Long-term Study of TAK-875
NCT01433406 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1222
Last updated 2014-01-27
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with TAK-875 in diabetic patients.
Conditions
Interventions
- DRUG
-
TAK-875
- DRUG
-
TAK-875
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Japan
Study Locations
More Related Trials
-
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
NCT01609582 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
NCT01413204 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
NCT01007097 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes
NCT01456195 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
NCT01572740 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
NCT01387737 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
NCT00763022 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study of Albiglutide in Japanese Subjects
NCT01098461 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
NCT03315780 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
NCT00762684 ·Status: TERMINATED ·Phase: PHASE3
-
SYR-472 Open-label Study
NCT01751360 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
NCT02750410 ·Status: COMPLETED ·Phase: PHASE4
-
TAK-875 Glimepiride Drug-Interaction Study
NCT01496443 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
NCT00532506 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
NCT01022112 ·Status: COMPLETED ·Phase: PHASE2
-
TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus
NCT02430870 ·Status: COMPLETED ·Phase: PHASE1
-
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
NCT00754130 ·Status: COMPLETED ·Phase: PHASE1
-
GW823093C For The Treatment Of Type 2 Diabetes Mellitus
NCT00370942 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
NCT00577824 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
NCT00530309 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
NCT00857558 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
NCT02227849 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
NCT00382239 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Study of SYR-472
NCT01431807 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294436 ·Status: COMPLETED ·Phase: PHASE3